We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+1.24%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.72B
AUM Growth
-$567M
Cap. Flow
-$487M
Cap. Flow %
-17.87%
Top 10 Hldgs %
35.33%
Holding
1,318
New
69
Increased
362
Reduced
661
Closed
226

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$38.5M
2
XOM icon
ExxonMobil
XOM
+$4.12M
3
CVX icon
Chevron
CVX
+$3.3M
4
COP icon
ConocoPhillips
COP
+$1.32M
5
CDE icon
Coeur Mining
CDE
+$1.13M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$71.9M
2
AAPL icon
Apple
AAPL
+$27M
3
AVGO icon
Broadcom
AVGO
+$24.6M
4
MSFT icon
Microsoft
MSFT
+$22.1M
5
META icon
Meta Platforms (Facebook)
META
+$17.8M

Sector Composition

Rank Sector Weight
1 Technology 43.05%
2 Healthcare 11.94%
3 Communication Services 9.58%
4 Consumer Discretionary 9.28%
5 Energy 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BTI icon
426
British American Tobacco
BTI
$129B
$753K 0.03%
12,884
-2,006
-13% -$119K
SSRM icon
427
SSR Mining
SSRM
$5.64B
$753K 0.03%
25,605
+797
+3% +$21.1K
EGO icon
428
Eldorado Gold
EGO
$8.33B
$746K 0.03%
21,738
+1,098
+5% +$44.7K
SAP icon
429
SAP
SAP
$171B
$746K 0.03%
4,358
-679
-13% -$140K
GSK icon
430
GSK
GSK
$102B
$742K 0.03%
13,453
-2,093
-13% -$113K
BX icon
431
Blackstone
BX
$152B
$742K 0.03%
6,455
-1,228
-16% -$160K
NVO
432
Novo Nordisk
NVO
$213B
$738K 0.03%
20,084
-3,126
-13% -$148K
CRVS icon
433
Corvus Pharmaceuticals
CRVS
$1.15B
$735K 0.03%
50,235
+13,172
+36% +$210K
KB icon
434
KB Financial Group
KB
$42.4B
$734K 0.03%
7,359
-996
-12% -$100K
CMI icon
435
Cummins
CMI
$91.8B
$730K 0.03%
1,357
+6
+0.4% +$3.4K
AKAM icon
436
Akamai
AKAM
$17.1B
$728K 0.03%
6,343
-1,075
-14% -$108K
AZO icon
437
AutoZone
AZO
$47.7B
$726K 0.03%
215
-36
-14% -$129K
FDX icon
438
FedEx
FDX
$74.7B
$724K 0.03%
2,034
+75
+4% +$26K
MRSH
439
Marsh
MRSH
$84.2B
$724K 0.03%
4,176
-921
-18% -$166K
ELV icon
440
Elevance Health
ELV
$82.3B
$722K 0.03%
2,467
-1,148
-32% -$377K
FFIV icon
441
F5
FFIV
$21.9B
$721K 0.03%
2,491
-484
-16% -$134K
NXT icon
442
Nextpower Inc
NXT
$15.8B
$720K 0.03%
5,970
-72
-1% -$7.98K
SNY icon
443
Sanofi
SNY
$104B
$712K 0.03%
14,779
-2,300
-13% -$107K
APA icon
444
APA Corp
APA
$12.9B
$712K 0.03%
16,774
+4,377
+35% +$132K
AZN icon
445
AstraZeneca
AZN
$261B
$710K 0.03%
3,600
-23,436
-87% -$4.52M
STLD icon
446
Steel Dynamics
STLD
$34.7B
$709K 0.03%
3,937
+553
+16% +$101K
EMR icon
447
Emerson Electric
EMR
$81.2B
$692K 0.03%
5,282
+210
+4% +$30.2K
UL icon
448
Unilever
UL
$130B
$691K 0.03%
12,126
+8,876
+273% +$595K
EMBJ
449
Embraer S.A. ADS
EMBJ
$11.7B
$690K 0.03%
11,625
+2,988
+35% +$205K
PPG icon
450
PPG Industries
PPG
$25.4B
$688K 0.03%
6,438
+904
+16% +$102K

Similar funds

Profund Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, Profund Advisors held 1,318 positions worth $2.72B, down 17% from $3.29B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Profund Advisors withdrew a net $487M in Q1 2026, closing 226 positions and reducing 661 holdings. Its most notable exit was Avidity Biosciences, an estimated $2.28M position sold in full.

By sector, the portfolio is most concentrated in Technology at 43% of assets, down from 46% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Profund Advisors opened a new position in Vertiv worth $962K.

  • Profund Advisors's largest Q1 2026 buy was Vertiv: 3,841 shares worth $962K.
  • Profund Advisors added most to Walmart Inc in Q1 2026, an estimated $38.5M increase.
  • Profund Advisors's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $71.9M.
  • Profund Advisors fully exited Avidity Biosciences in Q1 2026, selling an estimated $2.28M.
  • Profund Advisors's ten largest holdings make up 35% of its $2.72B portfolio in Q1 2026.
  • Profund Advisors opened 69 new positions and closed 226 in Q1 2026.
  • Profund Advisors's portfolio value fell 17% quarter-over-quarter to $2.72B.

Based on Profund Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.